Markus VON RAUMER

Person

Allschwil, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan
- Patent number 11,680,058
- Issue date Jun 20, 2023
- IDORSIA PHARMACEUTICALS LTD
- Martin Bolli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3...
- Patent number 11,555,025
- Issue date Jan 17, 2023
- IDORSIA PHARMACEUTICALS LTD
- Bibia Heidmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms
- Patent number 11,365,209
- Issue date Jun 21, 2022
- IDORSIA PHARMACEUTICALS LTD
- Daniel Leuenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclop...
- Patent number 11,339,148
- Issue date May 24, 2022
- IDORSIA PHARMACEUTICALS LTD
- Philippe Guerry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3...
- Patent number 11,059,803
- Issue date Jul 13, 2021
- IDORSIA PHARMACEUTICALS LTD
- Bibia Heidmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan
- Patent number 10,919,881
- Issue date Feb 16, 2021
- IDORSIA PHARMACEUTICALS LTD
- Martin Bolli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms
- Patent number 10,730,896
- Issue date Aug 4, 2020
- IDORSIA PHARMACEUTICALS LTD
- Daniel Leuenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms
- Patent number 10,351,560
- Issue date Jul 16, 2019
- IDORSIA PHARMACEUTICALS LTD
- Hamed Aissaoui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imida...
- Patent number 10,023,560
- Issue date Jul 17, 2018
- IDORSIA PHARMACEUTICALS LTD
- Christoph Boss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2...
- Patent number 9,914,720
- Issue date Mar 13, 2018
- IDORSIA PHARMACEUTICALS LTD
- Christoph Boss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imida...
- Patent number 9,790,208
- Issue date Oct 17, 2017
- IDORSIA PHARMACEUTICALS LTD
- Christoph Boss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz...
- Patent number 9,062,014
- Issue date Jun 23, 2015
- Actelion Pharmaceuticals Ltd.
- Nicholas Bonham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1...
- Patent number 8,492,555
- Issue date Jul 23, 2013
- Actelion Pharmaceuticals Ltd.
- Stefan Abele
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
A CRYSTALLINE FORM OF (4-METHYL-2-[1,2,3]TRIAZOL-2-YL-PHENYL)-[(R)-...
- Publication number 20240116913
- Publication date Apr 11, 2024
- IDORSIA PHARMACEUTICALS LTD
- Markus VON RAUMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN
- Publication number 20230391757
- Publication date Dec 7, 2023
- IDORSIA PHARMACEUTICALS LTD
- Martin BOLLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A STABLE CRYSTALLINE HYDRATE OF CLAZOSENTAN DISODIUM SALT
- Publication number 20230373967
- Publication date Nov 23, 2023
- IDORSIA PHARMACEUTICALS LTD
- Timo RAGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTA...
- Publication number 20230255987
- Publication date Aug 17, 2023
- IDORSIA PHARMACEUTICALS LTD
- Stephan BUCHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS
- Publication number 20220275011
- Publication date Sep 1, 2022
- IDORSIA PHARMACEUTICALS LTD
- Daniel LEUENBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDIN...
- Publication number 20220265658
- Publication date Aug 25, 2022
- IDORSIA PHARMACEUTICALS LTD
- Michael AMBUEHL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...
- Publication number 20220064149
- Publication date Mar 3, 2022
- IDORSIA PHARMACEUTICALS LTD
- Marc BELLET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...
- Publication number 20210300894
- Publication date Sep 30, 2021
- IDORSIA PHARMACEUTICALS LTD
- Bibia HEIDMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN
- Publication number 20210206750
- Publication date Jul 8, 2021
- IDORSIA PHARMACEUTICALS LTD
- Martin BOLLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF THE CXCR7 RECEPTOR ANTAGONIST (3S,4S)-1-CYCLOP...
- Publication number 20210115033
- Publication date Apr 22, 2021
- IDORSIA PHARMACEUTICALS LTD
- Philippe GUERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS
- Publication number 20210009614
- Publication date Jan 14, 2021
- IDORSIA PHARMACEUTICALS LTD
- Daniel LEUENBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...
- Publication number 20200165221
- Publication date May 28, 2020
- Bibia HEIDMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...
- Publication number 20200061061
- Publication date Feb 27, 2020
- IDORSIA PHARMACEUTICALS LTD
- Marc BELLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS
- Publication number 20200017534
- Publication date Jan 16, 2020
- IDORSIA PHARMACEUTICALS LTD
- Daniel LEUENBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN
- Publication number 20200002317
- Publication date Jan 2, 2020
- IDORSIA PHARMACEUTICALS LTD
- Martin BOLLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS
- Publication number 20190047996
- Publication date Feb 14, 2019
- IDORSIA PHARMACEUTICALS LTD
- Hamed AISSAOUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...
- Publication number 20180002317
- Publication date Jan 4, 2018
- Actelion Pharmaceuticals LTD
- Christoph BOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2...
- Publication number 20160368901
- Publication date Dec 22, 2016
- Actelion Pharmaceuticals LTD
- Christoph BOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...
- Publication number 20160355506
- Publication date Dec 8, 2016
- ACTELION PHARMACEUTICALS LTD
- Christoph BOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF ISOBUTYRIC ACID (1 R*,2R*,4R*) -2- (2- - ETHYL)-5-PHENYL-B...
- Publication number 20110263667
- Publication date Oct 27, 2011
- Stefan Abele
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (R) -5-[3-CHLORO-4-(2,3-DIHYDROXY-PROPOXY)-BEN...
- Publication number 20110196004
- Publication date Aug 11, 2011
- Nicholas Bonham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Markus VON RAUMER

Person

Patents Grantslast 30 patents

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3...

Crystalline forms

Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclop...

Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3...

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Crystalline forms

Crystalline forms

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imida...

Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2...

Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imida...

Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz...

Salts of isobutyric acid (1 R, 2R, 4R*)-2-(2-{[3-(4,7-dimethoxy-1...

Patents Applicationslast 30 patents

A CRYSTALLINE FORM OF (4-METHYL-2-[1,2,3]TRIAZOL-2-YL-PHENYL)-[(R)-...

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

A STABLE CRYSTALLINE HYDRATE OF CLAZOSENTAN DISODIUM SALT

AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTA...

CRYSTALLINE FORMS

PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDIN...

COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...

CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

CRYSTALLINE FORMS OF THE CXCR7 RECEPTOR ANTAGONIST (3S,4S)-1-CYCLOP...

CRYSTALLINE FORMS

CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...

COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...

CRYSTALLINE FORMS

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

CRYSTALLINE FORMS

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...

CRYSTALLINE FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2...

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...

SALTS OF ISOBUTYRIC ACID (1 R,2R,4R*) -2- (2- - ETHYL)-5-PHENYL-B...

CRYSTALLINE FORMS OF (R) -5-[3-CHLORO-4-(2,3-DIHYDROXY-PROPOXY)-BEN...

Markus VON RAUMER

Person

Patents Grantslast 30 patents

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3...

Crystalline forms

Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclop...

Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3...

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Crystalline forms

Crystalline forms

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imida...

Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2...

Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imida...

Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz...

Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1...

Patents Applicationslast 30 patents

A CRYSTALLINE FORM OF (4-METHYL-2-[1,2,3]TRIAZOL-2-YL-PHENYL)-[(R)-...

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

A STABLE CRYSTALLINE HYDRATE OF CLAZOSENTAN DISODIUM SALT

AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTA...

CRYSTALLINE FORMS

PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDIN...

COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...

CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

CRYSTALLINE FORMS OF THE CXCR7 RECEPTOR ANTAGONIST (3S,4S)-1-CYCLOP...

CRYSTALLINE FORMS

CRYSTALLINE FORM OF N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1 H-PYRAZOL-3...

COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGR...

CRYSTALLINE FORMS

CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN

CRYSTALLINE FORMS

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...

CRYSTALLINE FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2...

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDA...

SALTS OF ISOBUTYRIC ACID (1 R*,2R*,4R*) -2- (2- - ETHYL)-5-PHENYL-B...

CRYSTALLINE FORMS OF (R) -5-[3-CHLORO-4-(2,3-DIHYDROXY-PROPOXY)-BEN...

Salts of isobutyric acid (1 R, 2R, 4R*)-2-(2-{[3-(4,7-dimethoxy-1...

SALTS OF ISOBUTYRIC ACID (1 R,2R,4R*) -2- (2- - ETHYL)-5-PHENYL-B...